Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting

R.C. Lamb; F. Matcham; M.A. Turner; L. Rayner; A. Simpson; M. Hotopf; J.N.W.N. Barker; K. Jackson; C.H. Smith

doi:10.1111/bjd.14833

journal article Dec 29, 2016

Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting

R.C. Lamb F. Matcham M.A. Turner L. Rayner A. Simpson M. Hotopf J.N.W.N. Barker K. Jackson C.H. Smith

British Journal of Dermatology Vol. 176 No. 4 pp. 1028-1034 · Oxford University Press (OUP)

View at Publisher Save 10.1111/bjd.14833

Topics

No keywords indexed for this article. Browse by subject →

References

33

[1]

Rieder "Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implication and treatments" Int J Dermatol (2012) 10.1111/j.1365-4632.2011.05071.x

[2]

Richards "The contribution of perceptions of stigmatisation to disability in patients with psoriasis" J Psychosom Res (2001) 10.1016/s0022-3999(00)00210-5

[3]

Hunter "Does psychosocial stress play a role in exacerbation of psoriasis?" Br J Dermatol (2013) 10.1111/bjd.12478

[4]

National Institute for Health and Care Excellence Psoriasis: Assessment and Management http://www.nice.org.uk/CG153

[5]

Burden "Diagnosis and management of psoriasis and psoriatic arthritis in adults: summary of SIGN guidance" BMJ (2010) 10.1136/bmj.c5623

[6]

Rayner "Embedding integrated mental health assessment and management in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder" Gen Hosp Psychiatry (2014) 10.1016/j.genhosppsych.2013.12.004

[7]

The PHQ-9

Kurt Kroenke, Robert L. Spitzer, Janet B. W. Williams

Journal of General Internal Medicine 2001 10.1046/j.1525-1497.2001.016009606.x

[8]

Spitzer "A brief measure for assessing generalized anxiety disorder: the GAD-7" Arch Intern Med (2006) 10.1001/archinte.166.10.1092

[9]

Finlay "Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use" Clin Exp Dermatol (1994) 10.1111/j.1365-2230.1994.tb01167.x

[10]

Dbouk "Assessment of the PHQ-9 as a screening tool for depression in patients with chronic hepatitis C" Dig Dis Sci (2008) 10.1007/s10620-007-9985-z

[11]

Monahan "Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya" J Gen Intern Med (2009) 10.1007/s11606-008-0846-z

[12]

Williams "Performance of the PHQ-9 as a screening tool for depression after stroke" Stroke (2005) 10.1161/01.str.0000155688.18207.33

[13]

Lowe "Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population" Med Care (2008) 10.1097/mlr.0b013e318160d093

[14]

Seo "Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine" J Headache Pain (2015) 10.1186/s10194-015-0583-8

[15]

The Patient Health Questionnaire-2

Kurt Kroenke, Robert L. Spitzer, Janet B. W. Williams

Medical Care 2003 10.1097/01.mlr.0000093487.78664.3c

[16]

Kroenke "Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection" Ann Intern Med (2007) 10.7326/0003-4819-146-5-200703060-00004

[17]

Bewley A Affleck A Bundy C et al Working party report on minimum standards for psychodermatology services http://www.bad.org.uk/shared/get-file.ashx?itemtype=document&id=1622

[18]

Thompson "Psychosocial impact of skin conditions" Dermatol Nurs (2009)

[19]

Thompson "Treatment challenges: getting psychodermatology into the clinic" Dermatol Nurs (2014)

[20]

National Institute for Health and Care Excellence Depression in Adults with a Chronic Physical Health Problem: Treatment and Management www.nice.org.uk/guidance/cg91

[21]

Picardi "Suicide risk in skin disorders" Clin Dermatol (2013) 10.1016/j.clindermatol.2011.11.006

[22]

Hughes "Psychiatric symptoms in dermatology patients" Br J Psychiatry (1983) 10.1192/bjp.143.1.51

[23]

Golpour "Depression and anxiety disorders among patients with psoriasis: a hospital-based case-control study" Dermatol Res Pract (2012) 10.1155/2012/381905

[24]

Dowlatshahi "The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis" J Invest Dermatol (2014) 10.1038/jid.2013.508

[25]

Gupta "Suicidal ideation in psoriasis" Int J Dermatol (1993) 10.1111/j.1365-4362.1993.tb02790.x

[26]

Lowe "Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses" J Affect Disord (2004) 10.1016/s0165-0327(02)00237-9

[27]

Kurd "The risk of depression, anxiety, and suicidality in patients with psoriasis: a population based cohort study" Arch Dermatol (2010)

[28]

Huang "Using the patient health questionnaire-9 to measure depression among racially and ethnically diverse primary care patients" J Gen Intern Med (2006) 10.1111/j.1525-1497.2006.00409.x

[29]

Katon "The association of depression and anxiety with medical symptom burden in patients with chronic medical illness" Gen Hosp Psychiatry (2007) 10.1016/j.genhosppsych.2006.11.005

[30]

McDonough "Depression and anxiety in psoriatic disease: prevalence and associated factors" J Rheumatol (2014) 10.3899/jrheum.130797

[31]

Judd "The clinical course of unipolar major depressive disorders" Arch Gen Psychiatry (1997) 10.1001/archpsyc.1997.01830230015002

[32]

Gilbody "Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis" J Gen Intern Med (2007) 10.1007/s11606-007-0333-y

[33]

Langan "Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom" J Invest Dermatol (2012) 10.1038/jid.2011.365

Cited By

86

Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey

Mark Lebwohl, Richard G. Langley · 2021

Dermatology and Therapy

Metrics

86

Citations

33

References

Details

Published: Dec 29, 2016
Vol/Issue: 176(4)
Pages: 1028-1034
License: View

Authors

R

R.C. Lamb

St John's Institute of Dermatology; Guy's and St Thomas’ NHS Foundation Trust; Great Maze Pond London SE1 9RT U.K.

F

F. Matcham

Department of Psychological Medicine; Institute of Psychiatry, Psychology and Neuroscience; King's College London; Denmark Hill London SE5 9RJ U.K.

M

M.A. Turner

St John's Institute of Dermatology; Guy's and St Thomas’ NHS Foundation Trust; Great Maze Pond London SE1 9RT U.K.

L

L. Rayner

Department of Psychological Medicine; Institute of Psychiatry, Psychology and Neuroscience; King's College London; Denmark Hill London SE5 9RJ U.K.

A

A. Simpson

Department of Psychological Medicine; Institute of Psychiatry, Psychology and Neuroscience; King's College London; Denmark Hill London SE5 9RJ U.K.

M

M. Hotopf

Department of Psychological Medicine; Institute of Psychiatry, Psychology and Neuroscience; King's College London; Denmark Hill London SE5 9RJ U.K.

J

J.N.W.N. Barker

St John's Institute of Dermatology; Guy's and St Thomas’ NHS Foundation Trust; Great Maze Pond London SE1 9RT U.K.

K

K. Jackson

St John's Institute of Dermatology; Guy's and St Thomas’ NHS Foundation Trust; Great Maze Pond London SE1 9RT U.K.

C

C.H. Smith

St John's Institute of Dermatology; Guy's and St Thomas’ NHS Foundation Trust; Great Maze Pond London SE1 9RT U.K.

Funding

King’s College London

Guy's and St Thomas' NHS Foundation Trust

National Institute for Health Research

Cite This Article

R.C. Lamb, F. Matcham, M.A. Turner, et al. (2016). Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting. British Journal of Dermatology, 176(4), 1028-1034. https://doi.org/10.1111/bjd.14833

Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting

You May Also Like